U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820722) titled 'Assessing Heart and Brain Metabolism in Type II Diabetes Mellitus Patients Using Carbon-13... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821112) titled 'Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Tx Treated W... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820995) titled 'Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)' on Sept. 09.... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820384) titled 'The Effect of Time-Restricted Eating in 24-hour Metabolic Homeostasis and Diurnal Rhythm' ... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821268) titled 'Impact of Sedation Practices on Clinical Outcomes Among Mechanically Ventilated Children' ... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07819435) titled 'Phase 2/3 Efficacy and Safety of PP405 in Adult Males With NHS Type IV/V' on Sept. 09. Br... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820631) titled 'First-in-Human Study of the Circle Safe System for Diaphragm Response Monitoring During Pu... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820709) titled 'Artificial Intelligence for Staging Glaucoma Severity: A Comparison With an Eye Specialist... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821463) titled 'Epidemiology of PrImary Biliary Cholangitis in Spain' on Sept. 10. Brief Summary: Primary... Read More
U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07819838) titled 'Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Soli... Read More